4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-22-084838
Options or other derivatives
- Director acquired 7,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| NEIS JOHN Director | 2022-06-24 | Grant or award · Stock option (right to buy) | +7,800 | 7,800 | D | ||
Loading xslF345X03/tm2222253-4_4seq1.xml…